We are live on ! Find out more
ARAY icon

Accuray

127 hedge funds and large institutions have $274M invested in Accuray in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 51 increasing their positions, 39 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more call options, than puts

Call options by funds: $3.56M | Put options by funds: $2.48M

31% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 39

1.93% less ownership

Funds ownership: 82.47%80.54% (-1.9%)

9% less funds holding

Funds holding: 139127 (-12)

21% less capital invested

Capital invested by funds: $346M → $274M (-$71.3M)

40% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 25

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
127
Holders Change
-12
Holders Change %
-8.63%
% of All Funds
2.76%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
51
Reduced
39
Closed
25
Calls
$3.56M
Puts
$2.48M
Net Calls
+$1.09M
Net Calls Change
-$3.15M
Name Holding Trade Value Shares
Change
Change in
Stake
MSL
26
Mackay Shields LLC
New York
$2.4M +$1.29M +319,344 +106%
ARM
27
Adirondack Research & Management
New York
$2.06M
Squarepoint
28
Squarepoint
New York
$2.05M +$1.2M +297,114 +127%
DCM
29
DAFNA Capital Management
California
$2.03M +$2.12M +524,300 New
Citadel Advisors
30
Citadel Advisors
Florida
$1.93M -$514K -127,165 -20%
Wells Fargo
31
Wells Fargo
California
$1.91M -$496K -122,735 -20%
Fuller & Thaler Asset Management
32
Fuller & Thaler Asset Management
California
$1.9M -$9.61K -2,380 -0.5%
Deutsche Bank
33
Deutsche Bank
Germany
$1.71M -$596K -147,490 -25%
OAM
34
Oxford Asset Management
United Kingdom
$1.66M +$51.2K +12,673 +3%
Goldman Sachs
35
Goldman Sachs
New York
$1.43M +$299K +73,925 +25%
UBS Group
36
UBS Group
Switzerland
$1.24M +$280K +69,316 +28%
SIM
37
Spark Investment Management
New York
$1.2M -$299K -74,074 -19%
OAM
38
Ostrum Asset Management
France
$1.16M +$596K +147,503 +96%
CS
39
Candriam SCA
Luxembourg
$1.02M +$193K +47,800 +22%
OAM
40
Oberweis Asset Management
Illinois
$992K +$162K +40,000 +18%
Connor, Clark & Lunn Investment Management (CC&L)
41
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$967K +$108K +26,650 +12%
WCM
42
Wedge Capital Management
North Carolina
$938K +$979K +242,249 New
Morgan Stanley
43
Morgan Stanley
New York
$878K +$122K +30,200 +15%
CM
44
Crestline Management
Texas
$832K +$868K +215,000 New
SFM
45
Systematic Financial Management
New Jersey
$778K -$239K -59,130 -23%
SG Americas Securities
46
SG Americas Securities
New York
$766K +$758K +187,593 +1,822%
Two Sigma Investments
47
Two Sigma Investments
New York
$748K -$1.34M -332,288 -63%
Swiss National Bank
48
Swiss National Bank
Switzerland
$633K +$23K +5,700 +4%
MSE
49
MUFG Securities EMEA
United Kingdom
$629K -$217K -53,709 -25%
Two Sigma Advisers
50
Two Sigma Advisers
New York
$612K -$21.4K -5,300 -3%

ARAY Hedge Fund Activity: Q2 2019 in Review

127 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Accuray (ARAY) for Q2 2019, worth a combined $274M — down 21% from $346M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ARAY and 15 opened new positions — a net loss of 10 holders — while 39 trimmed existing stakes and 51 added.

The largest buyer was Russell Investments Group, adding an estimated $4.09M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $7.71M sold.

  • 127 institutional investors held Accuray (ARAY) as of Q2 2019, down from 139 in Q1 2019.
  • Funds reported $274M of Accuray stock for Q2 2019, down 21% quarter-over-quarter.
  • 15 funds opened new Accuray positions in Q2 2019 and 25 closed out, a net change of -10 holders.
  • The largest Accuray buyer in Q2 2019 was Russell Investments Group, an estimated $4.09M added.
  • The largest Accuray seller in Q2 2019 was PFM Health Sciences, an estimated $7.71M sold.

Based on aggregated 13F filings for Q2 2019.